Category: Pharmaceutical Information - Page 2

Medicaid Coverage for Prescription Medications: What’s Included in 2026

Natala Menezes
|
February 8
|
13

Medicaid covers prescription drugs for over 85 million Americans, but what’s included varies by state. Learn how formularies, step therapy, prior authorization, and copays work in 2026 - and how to get the drugs you need.

Epilepsy and Seizures: Types, Triggers, and Antiepileptic Medications

Natala Menezes
|
February 7
|
9

Epilepsy affects 50 million people worldwide. Understanding seizure types, triggers, and how antiepileptic drugs are chosen based on the latest 2025 ILAE classification can mean the difference between uncontrolled seizures and a full, active life.

How to Coordinate Care Between OB/GYN and Psychiatrist for Medications During Pregnancy and Breastfeeding

Natala Menezes
|
February 7
|
11

Learn how to coordinate care between your OB/GYN and psychiatrist during pregnancy and breastfeeding to safely manage psychiatric medications. Evidence-based guidelines show coordinated care reduces relapse, improves outcomes, and keeps both mother and baby safe.

Congressional Efforts to Tackle Drug Shortages: What the New Laws Really Mean

Natala Menezes
|
February 7
|
9

Two new congressional bills aim to tackle drug and healthcare provider shortages, but a historic government shutdown has stalled them. With hospitals in crisis and patients at risk, time is running out for meaningful action.

Medications and Driving: How Common Drugs Impair Your Ability to Drive and What It Means Legally

Natala Menezes
|
February 2
|
14

Many common medications impair driving more than people realize-even when you feel fine. Learn which drugs are risky, the legal consequences, and how to stay safe on the road.

How to Communicate Generic Substitution to Pediatric and Senior Patients

Natala Menezes
|
February 1
|
14

Learn how to explain generic drug substitutions to pediatric and senior patients in a way that builds trust, prevents confusion, and improves adherence. Understand the real differences between brand and generic meds-and how to communicate them clearly.

Sick Day Rules for Diabetes Medications: Preventing DKA and AKI

Natala Menezes
|
January 30
|
9

Learn the critical sick day rules for diabetes medications to prevent life-threatening DKA and AKI. Know when to stop metformin, SGLT2 inhibitors, and other drugs during illness-and what to do instead.

Antiseizure Medications and Generic Substitution: Risks and Best Practices

Natala Menezes
|
January 26
|
12

Generic antiseizure medications can save money-but for people with epilepsy, switching brands may trigger breakthrough seizures. Learn the risks, what the evidence shows, and how to protect your treatment.

Cardiovascular Combination Generics: Available Options and Practical Alternatives

Natala Menezes
|
January 26
|
15

Cardiovascular combination generics combine multiple heart meds into one pill to cut costs, simplify dosing, and improve adherence. Learn which combos are available, how they compare to brand names, and how to ask your doctor for them.

Why Not All Drugs Have Authorized Generics: The Hidden Rules Behind Generic Drug Availability

Natala Menezes
|
January 24
|
9

Not all drugs have authorized generics because brand manufacturers use them strategically to block competition-not to lower prices. Learn why some medications have cheaper versions and others don't.

Venlafaxine and Blood Pressure: What You Need to Know About Hypertension Risk

Natala Menezes
|
January 23
|
9

Venlafaxine can raise blood pressure, especially at higher doses. Learn how it happens, who’s at risk, what numbers to watch for, and how to monitor safely while treating depression or anxiety.

Rheumatoid Arthritis Remission: Treat-to-Target Strategies That Work

Natala Menezes
|
January 22
|
11

Treat-to-target strategies have transformed rheumatoid arthritis care, helping over 60% of patients achieve remission through structured monitoring, regular treatment adjustments, and clear goals like DAS28 scores. This is the most effective approach backed by decades of clinical trials.